exp3174 has been researched along with thapsigargin in 1 studies
| Studies (exp3174) | Trials (exp3174) | Recent Studies (post-2010) (exp3174) | Studies (thapsigargin) | Trials (thapsigargin) | Recent Studies (post-2010) (thapsigargin) |
|---|---|---|---|---|---|
| 236 | 29 | 43 | 5,234 | 3 | 918 |
| Protein | Taxonomy | exp3174 (IC50) | thapsigargin (IC50) |
|---|---|---|---|
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 0.002 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arguin, G; Auger-Messier, M; Chaloux, B; Escher, E; Guillemette, G; Leduc, R | 1 |
1 other study(ies) available for exp3174 and thapsigargin
| Article | Year |
|---|---|
Down-regulation of inositol 1,4,5-trisphosphate receptor in cells stably expressing the constitutively active angiotensin II N111G-AT(1) receptor.
Topics: Angiotensin II; Antihypertensive Agents; Calcium; Calcium Channels; Calcium Signaling; Cell Line; Down-Regulation; Embryo, Mammalian; Humans; Imidazoles; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Kidney; Losartan; Receptor, Angiotensin, Type 1; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Tetrazoles; Thapsigargin | 2004 |